Evidence map›Paper›PMID 18836750›Full record

ArticlePediatric nephrology (Berlin, Germany)2009

Nitric oxide synthase and renin-angiotensin gene expression and NOS function in the postnatal renal resistance vasculature.

Brian Ratliff, Justin Rodebaugh, Miroslav Sekulic, Ke-Wen Dong, Michael Solhaug

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Recent advances in research on nitrergic nerve-mediated vasodilatation.Pflugers Archiv : European journal of physiology · 2015
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Brian RatliffDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA, 23501-1980, USA.
Justin Rodebaugh
Miroslav Sekulic
Ke-Wen Dong
Michael Solhaug
Eastern Virginia Medical School · US

Funding

REGULATION OF DEVELOPMENTAL RENAL HEMODYNAMICSR01HL052765 · NHLBI · EASTERN VIRGINIA MEDICAL SCHOOL · PI SOLHAUG, MICHAEL JOHN · 1997 to 2005
$1.1M
NHLBI NIH HHS 2R01HL52765-04A2
6 · The paper itself

Abstract

Nitric oxide (NO), produced by nitric oxide synthase (NOS), critically counteracts angiotensin-II-enhanced vascular resistance in the immature kidney, perhaps due to the developmental regulation of NOS expression and function in the postnatal preglomerular resistance vessels (PRV). Our experiments measured the messenger ribonucleic acid (mRNA) gene expression of neuronal NOS (nNOS), endothelial NOS (eNOS), and components of the renin-angiotensin system (renin, AT1 and AT2 receptors), by real-time RT-PCR, as well as NOS enzymatic activity by citrulline assay in PRVs (afferent, interlobular, and arcuate arterioles) obtained from swine ages newborn, 7 and 21 days, and adult. NOS enzymatic activity was upregulated in PRVs immediately after birth but decreased to adult levels with maturation. Neuronal NOS, renin, and AT2 receptor expression in PRVs were upregulated in the newborn and decreased with age to lowest levels in the adult. In contrast, eNOS and AT1 receptor expression were downregulated at birth but increased to the highest levels in the adult. Upregulated NOS enzymatic activity in newborn PRVs supports the critical neonatal role for NO renal vascular vasodilation. Upregulated nNOS gene expression, concomitant with downregulated eNOS gene expression in neonatal PRVs, suggests that the nNOS isoform may be responsible for counteracting angiotensin II increased vascular resistance in immature porcine PRVs.

Indexed as

AnimalsGene Expression Regulation, DevelopmentalKidneyNitric Oxide Synthase Type INitric Oxide Synthase Type IIIReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2Renal CirculationReninReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSus scrofaVascular ResistanceVasoconstrictionNitric Oxide Synthase Type INitric Oxide Synthase Type IIIReceptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2ReninRNA, Messenger

Identifiers

PMID18836750
OpenAlexW2093680390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.